STAAR Surgical (NASDAQ:STAA) Major Shareholder Broadwood Partners, L.P. Purchases 93,124 Shares

STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. purchased 93,124 shares of the stock in a transaction dated Tuesday, March 18th. The stock was acquired at an average cost of $17.54 per share, for a total transaction of $1,633,394.96. Following the transaction, the insider now owns 12,074,275 shares of the company’s stock, valued at approximately $211,782,783.50. This trade represents a 0.78 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Thursday, March 20th, Broadwood Partners, L.P. purchased 108,720 shares of STAAR Surgical stock. The shares were bought at an average price of $17.96 per share, for a total transaction of $1,952,611.20.
• On Monday, March 3rd, Broadwood Partners, L.P. purchased 249,503 shares of STAAR Surgical stock. The stock was purchased at an average cost of $16.64 per share, for a total transaction of $4,151,729.92.
• On Thursday, February 27th, Broadwood Partners, L.P. acquired 259,316 shares of STAAR Surgical stock. The stock was bought at an average price of $17.05 per share, for a total transaction of $4,421,337.80.
• On Friday, February 14th, Broadwood Partners, L.P. purchased 36,532 shares of STAAR Surgical stock. The shares were acquired at an average price of $15.49 per share, for a total transaction of $565,880.68.
• On Wednesday, February 12th, Broadwood Partners, L.P. acquired 259,616 shares of STAAR Surgical stock. The stock was acquired at an average cost of $14.96 per share, with a total value of $3,883,855.36.
• On Thursday, January 16th, Broadwood Partners, L.P. purchased 8,221 shares of STAAR Surgical stock. The shares were bought at an average price of $21.50 per share, for a total transaction of $176,751.50.
• On Tuesday, January 14th, Broadwood Partners, L.P. acquired 21,155 shares of STAAR Surgical stock. The stock was acquired at an average price of $21.46 per share, for a total transaction of $453,986.30.

STAAR Surgical Stock Down 1.8 %

STAA stock opened at $17.92 on Friday. The business’s 50-day moving average price is $19.97 and its 200-day moving average price is $25.81. The stock has a market cap of $883.90 million, a P/E ratio of -43.71 and a beta of 0.66. STAAR Surgical has a twelve month low of $13.50 and a twelve month high of $52.68.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on STAA shares. William Blair cut STAAR Surgical from an “outperform” rating to a “market perform” rating in a research note on Wednesday, February 12th. Piper Sandler lowered their price objective on STAAR Surgical from $40.00 to $16.00 and set a “neutral” rating for the company in a research note on Wednesday, February 12th. Stephens reiterated an “equal weight” rating and set a $17.00 price target on shares of STAAR Surgical in a report on Tuesday. StockNews.com lowered STAAR Surgical from a “hold” rating to a “sell” rating in a research report on Thursday, February 13th. Finally, BTIG Research lowered shares of STAAR Surgical from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 12th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, STAAR Surgical has a consensus rating of “Hold” and a consensus price target of $25.29.

Hedge Funds Weigh In On STAAR Surgical

A number of hedge funds have recently modified their holdings of STAA. Quarry LP purchased a new position in shares of STAAR Surgical during the 3rd quarter valued at $50,000. Quest Partners LLC purchased a new stake in shares of STAAR Surgical during the third quarter worth about $128,000. KLP Kapitalforvaltning AS bought a new position in STAAR Surgical during the fourth quarter valued at approximately $180,000. Larson Financial Group LLC lifted its holdings in shares of STAAR Surgical by 78.3% in the 3rd quarter. Larson Financial Group LLC now owns 4,863 shares of the medical instruments supplier’s stock worth $181,000 after acquiring an additional 2,135 shares during the last quarter. Finally, Bridgefront Capital LLC boosted its stake in shares of STAAR Surgical by 27.2% during the 4th quarter. Bridgefront Capital LLC now owns 10,792 shares of the medical instruments supplier’s stock worth $262,000 after purchasing an additional 2,306 shares during the period. 96.70% of the stock is currently owned by institutional investors.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.